DalsnaFinance › Analyst accuracy › Stifel › GKOS target
Stifel reiterates Glaukos stock rating on strong Epioxa survey
Stifel reiterated a Buy rating and $190.00 price target on Glaukos Corporation following a bullish survey of the company's Epioxa product.
A fact about what Stifel published, as reported by Investing.com, not a recommendation from Dalsna Finance; Stifel is not affiliated with this site.
Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.